An activist fund run by Daniel Loeb is said to be amassing a stake in Dutch healthcare giant Philips ahead of a possible proxy war next year. Third Point, named for a wave break popular with surfers off of Malibu, could be looking to acquire a “multi-billion-euro position” in Philips, anonymous sources told the Times […]
Haemonetics (NYSE:HAE) said yesterday its CEO Brian Concannon resigned to pursue other opportunities and will be replaced by board member Ronald Gelbman, who will serve as interim CEO. The company said Concannon will remain with Haemonetics through the end of October to “ensure a seamless transition,” while the board searches for a permanent replacement. “Ron’s intimate […]
Xlumena said it closed a $25 million Series C round it plans to use to expand its commercial footprint and win FDA clearance for its Axios stent and delivery system.
Medical device company Avedro finished up a $43 million Series D financing round this week with the help of a pair of new investors, venture capital shops Third Point and Abingworth.
To tie the knot, Avedro is bringing on 2 new board members from its latest backers, Abingworth’s David Maye and Jason Hong of Third Point.
Avedro’s products are used primarily in support of Lasik laser eye surgery. The company is currently wrapping up Phase III clinical trials. Currently, none of the company’s products are for sale in the U.S.